• STJ72242 (0. 1µg/ml) staining of Human Colon lysate (35µg protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.

Anti-HOXA4 antibody (Internal) (STJ72242)

SKU:
STJ72242-100

Shipping:
Free Shipping
Current Stock:
Host: Goat
Applications: Pep-ELISA/WB
Reactivity: Human/Dog
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Goat polyclonal antibody anti-HOXA4 (Internal) is suitable for use in ELISA and Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. NA
Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Concentration: 0.5 mg/mL
Dilution Range: WB-0.1-0.3µg/ml
ELISA-antibody detection limit dilution 1:32000.
Storage Instruction: Store at-20°C on receipt and minimise freeze-thaw cycles.
Gene Symbol: HOXA4
Gene ID: 3201
Uniprot ID: HXA4_HUMAN
Immunogen Region: Internal
Accession Number: NP_002132.3
Immunogen Sequence: QAKGPAHGLHASH
Function Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis. Binds to sites in the 5'-flanking sequence of its coding region with various affinities. The consensus sequences of the high and low affinity binding sites are 5'-TAATGACG-3' and 5'-CTAATTTT-3'.
Protein Name Homeobox Protein Hox-A4
Homeobox Protein Hox-1.4
Homeobox Protein Hox-1d
Database Links Reactome: R-HSA-5617472
Cellular Localisation Nucleus
Alternative Antibody Names Anti-Homeobox Protein Hox-A4 antibody
Anti-Homeobox Protein Hox-1.4 antibody
Anti-Homeobox Protein Hox-1d antibody
Anti-HOXA4 antibody
Anti-HOX1D antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance